Curated scientific studies with plain-English summaries and multi-paradigm interpretation
Showing 3 studies
Grundy SM, et al. • Journal of the American College of Cardiology • 2019
Non-HDL-C is recommended as a secondary treatment target after LDL-C goals are achieved. For very high-risk patients, consider non-HDL-C <100 mg/dL.
NCEP ATP III • Circulation • 2002
Non-HDL-C target is set 30 mg/dL higher than LDL-C target. For high-risk patients: LDL-C <100 mg/dL corresponds to non-HDL-C <130 mg/dL.
NCEP ATP III • JAMA • 2001
ATP III criteria: presence of ≥3 of abdominal obesity (waist >102/88 cm), elevated TG (≥150), low HDL (<40/50), elevated BP (≥130/85), elevated fasting glucose (≥110, later revised to ≥100).